LOGO
LOGO

Will AtaiBeckley's Social Anxiety Disorder Trial Results Lift Investor Sentiment?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
social 19022026 lt

Eleanor Roosevelt, the former First Lady of the United States and diplomat, once observed, "You wouldn't worry so much about what others think of you if you realized how seldom they do." Yet for some individuals, the fear of being judged or negatively evaluated by others is overwhelming - a condition known as social anxiety disorder (SAD). In the United States alone, an estimated 18 million people are currently affected.

While several treatments are approved for SAD, no novel therapies have been introduced in more than two decades. The most recent FDA approvals date back to Effexor in 2003, Zoloft in 2002, and Paxil in 1999.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19